Correlation Between ABVC Biopharma and Erasca

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Erasca Inc, you can compare the effects of market volatilities on ABVC Biopharma and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Erasca.

Diversification Opportunities for ABVC Biopharma and Erasca

ABVCErascaDiversified AwayABVCErascaDiversified Away100%
-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between ABVC and Erasca is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Erasca go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Erasca

Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Erasca. In addition to that, ABVC Biopharma is 1.74 times more volatile than Erasca Inc. It trades about -0.02 of its total potential returns per unit of risk. Erasca Inc is currently generating about -0.01 per unit of volatility. If you would invest  278.00  in Erasca Inc on December 12, 2024 and sell it today you would lose (126.50) from holding Erasca Inc or give up 45.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ABVC Biopharma  vs.  Erasca Inc

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-200204060
JavaScript chart by amCharts 3.21.15ABVC ERAS
       Timeline  
ABVC Biopharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar0.40.50.60.70.8
Erasca Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Erasca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar1.522.53

ABVC Biopharma and Erasca Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-18.57-13.91-9.25-4.580.04.689.5314.3819.2224.07 0.0080.0100.0120.0140.0160.0180.0200.022
JavaScript chart by amCharts 3.21.15ABVC ERAS
       Returns  

Pair Trading with ABVC Biopharma and Erasca

The main advantage of trading using opposite ABVC Biopharma and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.
The idea behind ABVC Biopharma and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account